Michael Donegan
2016
In 2016, Michael Donegan earned a total compensation of $374.7K as Vice President - Finance at TherapeuticsMD, a 47% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $72,500 |
|---|---|
| Salary | $290,000 |
| Other | $12,176 |
| Total | $374,676 |
Donegan received $290K in salary, accounting for 77% of the total pay in 2016.
Donegan also received $72.5K in non-equity incentive plan and $12.2K in other compensation.
Rankings
In 2016, Michael Donegan's compensation ranked 12,111th out of 14,075 executives tracked by ExecPay. In other words, Donegan earned more than 14.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,111 out of 14,075 | 14th |
Division Manufacturing | 4,750 out of 5,489 | 14th |
Major group Chemicals And Allied Products | 1,692 out of 1,895 | 11th |
Industry group Drugs | 1,374 out of 1,538 | 11th |
Industry Pharmaceutical Preparations | 1,064 out of 1,176 | 10th |
Source: SEC filing on April 25, 2017.
Donegan's colleagues
We found four more compensation records of executives who worked with Michael Donegan at TherapeuticsMD in 2016.